BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Enveda Biosciences Recruits Former Lilly Chief Science Officer as New CSO

  Sotirios Karathanasis, Ph.D. brings broad drug discovery and development expertise to advance a pipeline of next-gen small molecules discovered by the Enveda platform.

  April 21, 2021

   · 

  3 min read
• Business

  Ambys Medicines Appoints Alan Smith, Ph.D., Chief Technology Officer

  Ambys Medicines, a cell and gene therapy company focused on advancing novel treatments to restore and regenerate liver function, announced today the appointment of Alan Smith, Ph.D., as the company’s new Chief Technology Officer.

  April 21, 2021

   · 

  2 min read
• Business

  Shareholders of Molecular Partners AG Approve all Board Proposals at the Annual General Meeting; Agnete Fredriksen and Dominik Höchli Elected New Board Members

  At todays AGM of Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, the shareholders of the company approved all motions proposed by the Board of Directors with a very large majority.

  April 21, 2021

   · 

  4 min read